Erbitux (cetuximab) - Eli Lilly
BND-22 - Biond Biologics, Sanofi
Keytruda (pembrolizumab) - Merck (MSD)
https://dx.doi.org/10.1136/jitc-2024-SITC2024.0623
 
Ruth Perets1; Salomon M Stemmer2; Ravit Geva3; Talia Golan4; Marwan G Fakih5; Jonathan Cohen6; Christopher Lieu7; Jin Zhaohui8; Patricia LoRusso9; Itay Friedman10; Motti Hakim10; Dana Haves Ziv10; Sharon Hashmueli10; Ilana Mandel10; Tehila Ben Moshe10; Nigel Crawford11; Giovanni Abbadessa12; Raymond Perez11; Meijing Wu12; Mitesh Borad13
 
Oct 4, 2024
 
Prev Next